Aldeyra Therapeutics, Inc. Made Headway
Tue, Apr 27, 2021 at 05:30 PM
Aldeyra Therapeutics, Inc. (ALDX:NASDAQ) shot up at $14.85, a gain of 33.7%. The stock got featured on our News Catalysts scanner on Tue, Apr 27, 2021 at 04:32 PM in the 'PUBLIC OFFERING' category. From Mon, Apr 12, 2021, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Feb 16, 2021 at $14.52 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About Aldeyra Therapeutics, Inc. (ALDX:NASDAQ)
Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.
Top 10 Gainers:
- TerraForm Global, Inc. (GLBL:NASDAQ), 100%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 51.18%
- Urban Tea, Inc. (MYT:NASDAQ), 38.1%
- Vaxart, Inc. (VXRT:NASDAQ), 37.46%
- TIRX (TIRX:NASDAQ), 36.27%
- Aldeyra Therapeutics, Inc. (ALDX:NASDAQ), 33.66%
- RiceBran Technologies (RIBT:NASDAQ), 26.88%
- NetSol Technologies, Inc. (NTWK:NASDAQ), 25.29%
- TrueBlue, Inc. (TBI:NYSE), 24.89%
- EEIQ (EEIQ:NASDAQ), 21.23%